Lansoprazole Delayed-Release Capsules USP (15 mg), a 24-hour acid reducer used to treat frequent heartburn, are being recalled. This recall affects 30 bottles of the medication distributed by Rising Pharma Holdings, Inc. and manufactured by NATCO Pharma Limited. The recall was issued because the products were made in a facility that deviated from Current Good Manufacturing Practice (CGMP) standards. If you have health concerns after using this medication, you should contact your doctor or pharmacist.
Manufacturing deviations can mean the drug was not made according to safety and quality standards, which could potentially compromise its purity or effectiveness. While no specific health issues have been reported for this small batch of 30 bottles, using drugs that do not meet manufacturing standards poses a potential health risk.
You have 2 options:
Manufactured by NATCO Pharma Limited (India) and distributed by Rising Pharma Holdings, Inc. (East Brunswick, NJ).
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.